Quality of life and cost of multiple sclerosis
- 1 July 2002
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 104 (3) , 272-275
- https://doi.org/10.1016/s0303-8467(02)00051-3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Health-Related Quality of Life (HR-QOL) and Regulatory IssuesPharmacoEconomics, 2001
- Hochrechnung der Zahl an Multiple Sklerose erkrankten Patienten in DeutschlandDer Nervenarzt, 2000
- Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisThe Lancet, 1998
- Burden of Illness of Multiple Sclerosis: Part I: Cost of IllnessCanadian Journal of Neurological Sciences, 1998
- The Economic Cost of Multiple Sclerosis in Sweden in 1994PharmacoEconomics, 1998
- Interferon-β in Multiple Sclerosis Can We Control its Costs?PharmacoEconomics, 1997
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Impairment, disability and handicap in multiple sclerosis A cross-sectional study in an incident cohort in M re and Romsdal County, NorwayZeitschrift für Neurologie, 1996
- How Many People in the World Have Multiple Sclerosis?Neuroepidemiology, 1994
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993